GH1 and sarcopenia: In humans, GH and IGF-1 levels peak during puberty, decline during aging [35], and coincide with unfavorable effects on mitochondrial metabolism in brain (cognition [36]), muscle (sarcopenia [2]), and skeletal tissue (osteopenia [1]).